Lymphedema Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Lymphedema Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Lymphedema Diagnostics Market by Technology
3.3.1: X-ray Lymphography
3.3.2: Lymphoscintigraphy
3.3.3: Computed Tomography
3.3.4: Ultrasound Imaging
3.3.5: Magnetic Resonance Imaging
3.3.6: Bioimpedance Analysis
3.3.7: Near-infrared Fluorescence Imaging
3.3.8: ICG Lymphography
3.3.9: Fluorescein Sodium Microlymphangiography
3.4: Global Lymphedema Diagnostics Market by Disease Type
3.4.1: Cancer
3.4.2: Cardiovascular Diseases
3.4.3: Inflammatory Diseasess
3.4.4: Others
3.5: Global Lymphedema Diagnostics Market by End Use
3.5.1: Hospitals
3.5.2: Diagnostic Centers
3.5.3: Research & Academic Institutes
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Lymphedema Diagnostics Market by Region
4.2: North American Lymphedema Diagnostics Market
4.2.1: North American Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.2.2: North American Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
4.3: European Lymphedema Diagnostics Market
4.3.1: European Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.3.2: European Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
4.4: APAC Lymphedema Diagnostics Market
4.4.1: APAC Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.4.2: APAC Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
4.5: ROW Lymphedema Diagnostics Market
4.5.1: ROW Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.5.2: ROW Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Lymphedema Diagnostics Market by Technology
6.1.2: Growth Opportunities for the Global Lymphedema Diagnostics Market by Diseases Type
6.1.3: Growth Opportunities for the Global Lymphedema Diagnostics Market by End Use
6.1.4: Growth Opportunities for the Global Lymphedema Diagnostics Market by Region
6.2: Emerging Trends in the Global Lymphedema Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Lymphedema Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lymphedema Diagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: GE Healthcare
7.2: Philips
7.3: Siemens Healthineers
7.4: Canon
7.5: Shimadzu
7.6: Stryker
7.7: Fluoptics
7.8: United Imaging Healthcare
7.9: Hitachi
7.10: Esaote
2. GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Lymphedema Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Lymphedema Diagnostics Market by Technology
3.3.1: X-ray Lymphography
3.3.2: Lymphoscintigraphy
3.3.3: Computed Tomography
3.3.4: Ultrasound Imaging
3.3.5: Magnetic Resonance Imaging
3.3.6: Bioimpedance Analysis
3.3.7: Near-infrared Fluorescence Imaging
3.3.8: ICG Lymphography
3.3.9: Fluorescein Sodium Microlymphangiography
3.4: Global Lymphedema Diagnostics Market by Disease Type
3.4.1: Cancer
3.4.2: Cardiovascular Diseases
3.4.3: Inflammatory Diseasess
3.4.4: Others
3.5: Global Lymphedema Diagnostics Market by End Use
3.5.1: Hospitals
3.5.2: Diagnostic Centers
3.5.3: Research & Academic Institutes
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Lymphedema Diagnostics Market by Region
4.2: North American Lymphedema Diagnostics Market
4.2.1: North American Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.2.2: North American Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
4.3: European Lymphedema Diagnostics Market
4.3.1: European Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.3.2: European Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
4.4: APAC Lymphedema Diagnostics Market
4.4.1: APAC Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.4.2: APAC Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
4.5: ROW Lymphedema Diagnostics Market
4.5.1: ROW Lymphedema Diagnostics Market by Diseases Type: Cancer, Cardiovascular Diseases, Inflammatory Diseasess, and Others
4.5.2: ROW Lymphedema Diagnostics Market by End Use: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Lymphedema Diagnostics Market by Technology
6.1.2: Growth Opportunities for the Global Lymphedema Diagnostics Market by Diseases Type
6.1.3: Growth Opportunities for the Global Lymphedema Diagnostics Market by End Use
6.1.4: Growth Opportunities for the Global Lymphedema Diagnostics Market by Region
6.2: Emerging Trends in the Global Lymphedema Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Lymphedema Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lymphedema Diagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: GE Healthcare
7.2: Philips
7.3: Siemens Healthineers
7.4: Canon
7.5: Shimadzu
7.6: Stryker
7.7: Fluoptics
7.8: United Imaging Healthcare
7.9: Hitachi
7.10: Esaote
